Home
Life sciences, pharmaceuticals and medical devices
Separate market authorisation, reimbursement, clinical evidence, promotional claims and intellectual property.
Separate market authorisation, reimbursement, clinical evidence, promotional claims and intellectual property. Changes in intended purpose, manufacturing or distribution can affect different approvals and agreements.
Practical examples
Medical software
Document intended purpose and the evidence supporting classification.
Clinical collaboration
Agree access to trial data, publication rights and ownership.
Pharmaceutical launch
Coordinate regulatory milestones with patent and SPC review.
Distributor audit
Match marketing materials and reporting procedures to the authorised product.